Clinical Trials Browser

Withdrawn × Gliosarcoma × Sorafenib × Clear all

NCT02599090 2015-11-06

Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Phase 2 Withdrawn

Brain Neoplasms, Glioblastoma, Gliosarcoma